We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Supernus Pharmaceuticals

News List

Supernus Sues Apotex for Infringement of Oxtellar XR® Patents americanpharmaceuticalreview
July 07, 2020
Supernus Pharmaceuticals announced it has sued generic drug maker Apotex Inc. and Apotex Corp. for infringement of nine patents covering its antiepileptic drug Oxtellar XR®.
Pharma industry witnesses 50 deals worth $3 billion in April 2020 expresspharma
May 08, 2020
Three major deals contributed 72 per cent of deal value in April 2020.
Cadila Healthcare in pact with Supernus Pharmaceuticals expressbpd
March 10, 2017
Under the terms of the pact, Supernus grants a license to market Zydus generic version of Trokendi XR (topiramate) extended-release capsules beginning on January 1, 2023